Cyanosis risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 38: Line 38:
****[[Chronic obstructive pulmonary disease|COPD]]
****[[Chronic obstructive pulmonary disease|COPD]]
****[[Bronchiectasis|Bronchiactasis]]
****[[Bronchiectasis|Bronchiactasis]]
***'''Vasculature (Q):'''
***'''Vasculature (Q):'''<ref name="pmid18272123">{{cite journal |vauthors=Wang RF, Hung TY, Chong CF, Wang TL, Chen CC |title=Central cyanosis due to severe pulmonary hypertension combined with pericarditis as the initial manifestation of systemic lupus erythematosus |journal=Am J Emerg Med |volume=26 |issue=2 |pages=248.e1–2 |date=February 2008 |pmid=18272123 |doi=10.1016/j.ajem.2007.04.007 |url=}}</ref><ref name="pmid11596167">{{cite journal |vauthors=Grech V, Goldman A |title=Acute respiratory distress syndrome due to cyanotic spell in an infant with tetralogy of Fallot |journal=Pediatr. Pulmonol. |volume=32 |issue=5 |pages=406–7 |date=November 2001 |pmid=11596167 |doi= |url=}}</ref>
****[[Acute chest syndrome]] due to [[Sickle-cell disease|sickle cell disease]]
****[[Acute chest syndrome]] due to [[Sickle-cell disease|sickle cell disease]]
****[[Pulmonary embolism|Pulmonary embolus]]
****[[Pulmonary embolism|Pulmonary embolus]]
Line 51: Line 51:
***[[Pulmonary edema]]
***[[Pulmonary edema]]
*Intracardiac or vascular shunts may cause [[cyanosis]] by mixing oxygenated and deoxygenated blood.
*Intracardiac or vascular shunts may cause [[cyanosis]] by mixing oxygenated and deoxygenated blood.
**[[Congenital heart disease|Congenital heart diseases]]<ref name="pmid18851735">{{cite journal |vauthors=Martins P, Castela E |title=Transposition of the great arteries |journal=Orphanet J Rare Dis |volume=3 |issue= |pages=27 |date=October 2008 |pmid=18851735 |pmc=2577629 |doi=10.1186/1750-1172-3-27 |url=}}</ref><ref name="pmid13019603">{{cite journal |vauthors=POTTS WJ |title=[Congenital heart disease cyanotic children] |language=Undetermined |journal=Calif Med |volume=78 |issue=2 |pages=101–3 |date=February 1953 |pmid=13019603 |pmc=1521678 |doi= |url=}}</ref>
**[[Congenital heart disease|Congenital heart diseases]]<ref name="pmid18851735">{{cite journal |vauthors=Martins P, Castela E |title=Transposition of the great arteries |journal=Orphanet J Rare Dis |volume=3 |issue= |pages=27 |date=October 2008 |pmid=18851735 |pmc=2577629 |doi=10.1186/1750-1172-3-27 |url=}}</ref><ref name="pmid13019603">{{cite journal |vauthors=POTTS WJ |title=[Congenital heart disease cyanotic children] |language=Undetermined |journal=Calif Med |volume=78 |issue=2 |pages=101–3 |date=February 1953 |pmid=13019603 |pmc=1521678 |doi= |url=}}</ref><ref name="pmid6021453">{{cite journal |vauthors=Just-Viera JO, Norwood T, Yeager GH |title=Importance of shock and cyanosis in pulmonary embolism |journal=Ann. Surg. |volume=165 |issue=4 |pages=528–35 |date=April 1967 |pmid=6021453 |pmc=1617449 |doi= |url=}}</ref>
***[[Tetralogy of Fallot|Tetralogy of fallot]]
***[[Tetralogy of Fallot|Tetralogy of fallot]]
***Tricuspid valve anomalies
***Tricuspid valve anomalies

Revision as of 17:03, 9 March 2018

Cyanosis Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cyanosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cyanosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cyanosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cyanosis risk factors

CDC on Cyanosis risk factors

Cyanosis risk factors in the news

Blogs on Cyanosis risk factors

Directions to Hospitals Treating Cyanosis

Risk calculators and risk factors for Cyanosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]

Overview

Common risk factors in the development of cyanosis include congenital heart diseases with right to left shunting, presence of abnormal hemoglobin, carbon monoxide poisoning, respiratory disorders associated with impaired gas exchange, impaired gas diffusion via the alveoli, embolism, pulmonary arteriovenous malformations, cold exposure, and raynaud's phenomenon.

Risk Factors

The risk factors for cyanosis include:


References

  1. Blumenthal I (June 2001). "Carbon monoxide poisoning". J R Soc Med. 94 (6): 270–2. PMC 1281520. PMID 11387414.
  2. Zoorob RJ, Campbell JS (November 2003). "Acute dyspnea in the office". Am Fam Physician. 68 (9): 1803–10. PMID 14620600.
  3. Ranjit MS (March 2000). "Cardiac abnormalities in birth asphyxia". Indian J Pediatr. 67 (3 Suppl): S26–9. PMID 11129917.
  4. Wang RF, Hung TY, Chong CF, Wang TL, Chen CC (February 2008). "Central cyanosis due to severe pulmonary hypertension combined with pericarditis as the initial manifestation of systemic lupus erythematosus". Am J Emerg Med. 26 (2): 248.e1–2. doi:10.1016/j.ajem.2007.04.007. PMID 18272123.
  5. Grech V, Goldman A (November 2001). "Acute respiratory distress syndrome due to cyanotic spell in an infant with tetralogy of Fallot". Pediatr. Pulmonol. 32 (5): 406–7. PMID 11596167.
  6. Martins P, Castela E (October 2008). "Transposition of the great arteries". Orphanet J Rare Dis. 3: 27. doi:10.1186/1750-1172-3-27. PMC 2577629. PMID 18851735.
  7. POTTS WJ (February 1953). "[Congenital heart disease cyanotic children]". Calif Med (in Undetermined). 78 (2): 101–3. PMC 1521678. PMID 13019603.
  8. Just-Viera JO, Norwood T, Yeager GH (April 1967). "Importance of shock and cyanosis in pulmonary embolism". Ann. Surg. 165 (4): 528–35. PMC 1617449. PMID 6021453.

Template:WH Template:WS